Eisai Co., Ltd. (4523.T)
JPY 4338.0
(-0.28%)
JPY 4338.0
(-0.28%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 533.01 Billion JPY | -1.81% |
| 2022 | 526.52 Billion JPY | -0.21% |
| 2021 | 527.64 Billion JPY | 21.9% |
| 2020 | 432.86 Billion JPY | 9.75% |
| 2019 | 394.42 Billion JPY | 5.98% |
| 2018 | 372.18 Billion JPY | 15.73% |
| 2017 | 321.58 Billion JPY | 13.18% |
| 2016 | 284.12 Billion JPY | -5.77% |
| 2015 | 301.52 Billion JPY | -7.66% |
| 2014 | 326.53 Billion JPY | -4.27% |
| 2013 | 341.08 Billion JPY | 3.64% |
| 2012 | 329.1 Billion JPY | -13.12% |
| 2011 | 378.82 Billion JPY | -22.38% |
| 2010 | 488.02 Billion JPY | -12.23% |
| 2009 | 556 Billion JPY | 3.45% |
| 2008 | 537.48 Billion JPY | -10.08% |
| 2007 | 597.73 Billion JPY | 30.07% |
| 2006 | 459.54 Billion JPY | 14.59% |
| 2005 | 401.04 Billion JPY | 15.34% |
| 2004 | 347.71 Billion JPY | 8.7% |
| 2003 | 319.88 Billion JPY | 11.01% |
| 2002 | 288.14 Billion JPY | 11.9% |
| 2001 | 257.49 Billion JPY | 26.13% |
| 2000 | 204.14 Billion JPY | 17.56% |
| 1999 | 173.65 Billion JPY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 135.86 Billion JPY | -8.16% |
| 2023 Q2 | 134.79 Billion JPY | 6.14% |
| 2023 FY | 517.02 Billion JPY | -1.81% |
| 2023 Q4 | 147.92 Billion JPY | 11.47% |
| 2023 Q3 | 132.71 Billion JPY | -1.54% |
| 2023 Q1 | 126.98 Billion JPY | -4.82% |
| 2022 FY | 526.52 Billion JPY | -0.21% |
| 2022 Q2 | 131.41 Billion JPY | 1.54% |
| 2022 Q3 | 132.26 Billion JPY | 0.65% |
| 2022 Q4 | 133.42 Billion JPY | 0.88% |
| 2022 Q1 | 129.42 Billion JPY | -19.6% |
| 2021 FY | 527.64 Billion JPY | 21.9% |
| 2021 Q2 | 117.33 Billion JPY | 12.57% |
| 2021 Q1 | 104.23 Billion JPY | -7.25% |
| 2021 Q3 | 145.1 Billion JPY | 23.66% |
| 2021 Q4 | 160.96 Billion JPY | 10.93% |
| 2020 Q1 | 95.18 Billion JPY | -12.58% |
| 2020 FY | 432.86 Billion JPY | 9.75% |
| 2020 Q2 | 108.07 Billion JPY | 13.54% |
| 2020 Q4 | 112.38 Billion JPY | -4.13% |
| 2020 Q3 | 117.22 Billion JPY | 8.47% |
| 2019 Q3 | 101.48 Billion JPY | 2.73% |
| 2019 FY | 394.42 Billion JPY | 5.98% |
| 2019 Q1 | 85.28 Billion JPY | -17.82% |
| 2019 Q4 | 108.88 Billion JPY | 7.3% |
| 2019 Q2 | 98.78 Billion JPY | 15.82% |
| 2018 Q4 | 103.78 Billion JPY | 5.18% |
| 2018 Q2 | 85.05 Billion JPY | 0.45% |
| 2018 Q1 | 84.67 Billion JPY | 0.16% |
| 2018 Q3 | 98.67 Billion JPY | 16.02% |
| 2018 FY | 372.18 Billion JPY | 15.73% |
| 2017 FY | 321.58 Billion JPY | 13.18% |
| 2017 Q3 | 81.86 Billion JPY | 5.14% |
| 2017 Q2 | 77.86 Billion JPY | 0.7% |
| 2017 Q1 | 77.32 Billion JPY | -3.84% |
| 2017 Q4 | 84.53 Billion JPY | 3.27% |
| 2016 Q2 | 71.81 Billion JPY | 17.17% |
| 2016 FY | 284.12 Billion JPY | -5.77% |
| 2016 Q3 | 70.6 Billion JPY | -1.69% |
| 2016 Q1 | 61.29 Billion JPY | -16.05% |
| 2016 Q4 | 80.4 Billion JPY | 13.88% |
| 2015 Q1 | 82.22 Billion JPY | -3.23% |
| 2015 Q2 | 75.7 Billion JPY | -7.93% |
| 2015 Q4 | 73.01 Billion JPY | 3.44% |
| 2015 Q3 | 70.58 Billion JPY | -6.77% |
| 2015 FY | 301.52 Billion JPY | -7.66% |
| 2014 Q1 | 76.23 Billion JPY | -1.55% |
| 2014 Q4 | 84.96 Billion JPY | 0.74% |
| 2014 Q2 | 80.99 Billion JPY | 6.25% |
| 2014 Q3 | 84.34 Billion JPY | 4.13% |
| 2014 FY | 326.53 Billion JPY | -4.27% |
| 2013 Q2 | 78.22 Billion JPY | -16.61% |
| 2013 FY | 341.08 Billion JPY | 3.64% |
| 2013 Q4 | 77.43 Billion JPY | -10.24% |
| 2013 Q3 | 86.27 Billion JPY | 10.29% |
| 2013 Q1 | 93.8 Billion JPY | 17.53% |
| 2012 Q3 | 83.13 Billion JPY | 1.9% |
| 2012 Q4 | 79.81 Billion JPY | -3.99% |
| 2012 Q1 | 84.57 Billion JPY | -1.14% |
| 2012 FY | 329.1 Billion JPY | -13.12% |
| 2012 Q2 | 81.57 Billion JPY | -3.55% |
| 2011 Q4 | 85.55 Billion JPY | -13.03% |
| 2011 Q2 | 92.82 Billion JPY | -9.06% |
| 2011 FY | 378.82 Billion JPY | -22.38% |
| 2011 Q1 | 102.07 Billion JPY | -7.98% |
| 2011 Q3 | 98.36 Billion JPY | 5.97% |
| 2010 Q1 | 128.14 Billion JPY | -18.96% |
| 2010 Q4 | 110.92 Billion JPY | -4.48% |
| 2010 FY | 488.02 Billion JPY | -12.23% |
| 2010 Q3 | 116.12 Billion JPY | -12.57% |
| 2010 Q2 | 132.82 Billion JPY | 3.65% |
| 2009 Q3 | 130.93 Billion JPY | -2.84% |
| 2009 Q4 | 158.12 Billion JPY | 20.76% |
| 2009 FY | 556 Billion JPY | 3.45% |
| 2009 Q1 | 132.18 Billion JPY | 0.86% |
| 2009 Q2 | 134.76 Billion JPY | 1.95% |
| 2008 Q3 | 133.35 Billion JPY | -5.19% |
| 2008 FY | 537.48 Billion JPY | -10.08% |
| 2008 Q1 | 132.4 Billion JPY | 0.0% |
| 2008 Q2 | 140.65 Billion JPY | 6.23% |
| 2008 Q4 | 131.06 Billion JPY | -1.72% |
| 2007 FY | 597.73 Billion JPY | 30.07% |
| 2006 FY | 459.54 Billion JPY | 14.59% |
| 2005 FY | 401.04 Billion JPY | 15.34% |
| 2004 FY | 347.71 Billion JPY | 8.7% |
| 2003 FY | 319.88 Billion JPY | 11.01% |
| 2002 FY | 288.14 Billion JPY | 11.9% |
| 2001 FY | 257.49 Billion JPY | 26.13% |
| 2000 FY | 204.14 Billion JPY | 17.56% |
| 1999 FY | 173.65 Billion JPY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 43.63 Billion JPY | -1121.407% |
| Takeda Pharmaceutical Company Limited | 2618.18 Billion JPY | 79.642% |
| Sumitomo Pharma Co., Ltd. | 542.17 Billion JPY | 1.69% |
| Shionogi & Co., Ltd. | 197.62 Billion JPY | -169.706% |
| Wakamoto Pharmaceutical Co.,Ltd. | 3.73 Billion JPY | -14165.492% |
| Nippon Shinyaku Co., Ltd. | 65.63 Billion JPY | -712.131% |
| Kaken Pharmaceutical Co., Ltd. | 29.02 Billion JPY | -1736.319% |
| Morishita Jintan Co., Ltd. | 5.28 Billion JPY | -9991.064% |
| Hisamitsu Pharmaceutical Co., Inc. | 65.8 Billion JPY | -709.996% |
| Mochida Pharmaceutical Co., Ltd. | 46.26 Billion JPY | -1052.031% |
| Fuso Pharmaceutical Industries,Ltd. | 11.55 Billion JPY | -4513.607% |
| Nippon Chemiphar Co., Ltd. | 8.23 Billion JPY | -6374.854% |
| Tsumura & Co. | 48.8 Billion JPY | -992.234% |
| Kissei Pharmaceutical Co., Ltd. | 33.32 Billion JPY | -1499.478% |
| Torii Pharmaceutical Co., Ltd. | 19.53 Billion JPY | -2628.208% |
| Towa Pharmaceutical Co., Ltd. | 63.73 Billion JPY | -736.278% |
| Fuji Pharma Co., Ltd. | 12.65 Billion JPY | -4111.187% |
| Zeria Pharmaceutical Co., Ltd. | 40.46 Billion JPY | -1217.223% |
| KYORIN Holdings, Inc. | 45.39 Billion JPY | -1074.16% |
| Taiko Pharmaceutical Co.,Ltd. | 4.15 Billion JPY | -12721.987% |
| Daito Pharmaceutical Co.,Ltd. | 5.94 Billion JPY | -8865.685% |
| SymBio Pharmaceuticals Limited | 5.22 Billion JPY | -10105.678% |
| MedRx Co., Ltd | 959 Million JPY | -55479.771% |
| Mizuho Medy Co.,Ltd. | 2.87 Billion JPY | -18447.678% |
| Solasia Pharma K.K. | 1.47 Billion JPY | -36011.789% |
| Modalis Therapeutics Corporation | 2.37 Billion JPY | -22383.565% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 24.16 Billion JPY | -2105.711% |
| Sawai Group Holdings Co., Ltd. | 35.43 Billion JPY | -1404.276% |
| Cyfuse Biomedical K.K. | 735.18 Million JPY | -72400.513% |
| Toho Holdings Co., Ltd. | 99.81 Billion JPY | -433.987% |
| Koa Shoji Holdings Co.,Ltd. | 2.25 Billion JPY | -23512.859% |